Cantor Fitzgerald Downgrades Apellis Pharmaceuticals (APLS) to Neutral Apr 1, 2026 02:52AM
Apellis Pharmaceuticals (APLS) PT Lowered to $31 at Cantor Fitzgerald Mar 18, 2026 06:56AM
Apellis Pharmaceuticals (APLS) Reiterated at Overweight by Cantor Fitzgerald Jan 16, 2026 07:02AM
Apellis Pharmaceuticals (APLS) Reiterated at Overweight by Cantor Fitzgerald Jan 13, 2026 07:11AM
Apellis Pharmaceuticals (APLS) PT Raised to $40 at Cantor Fitzgerald Aug 1, 2025 08:40AM


Jul 29, 2025 08:36AM Cantor Fitzgerald Reiterates Overweight Rating on Apellis Pharmaceuticals (APLS)
Jul 10, 2025 06:40AM Cantor Fitzgerald Reiterates Overweight Rating on Apellis Pharmaceuticals (APLS)
Apr 29, 2025 06:32AM Cantor Fitzgerald Starts Apellis Pharmaceuticals (APLS) at Overweight
Jan 13, 2020 12:10PM Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Jan 13, 2020 12:10PM Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Jan 9, 2020 05:55AM Apellis Pharmaceuticals (APLS) Prices 9.5M Share Offering at $37/Sh
Jan 8, 2020 09:30PM Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jan 8, 2020 09:30PM Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jan 7, 2020 08:08AM Apellis Pharmaceuticals (APLS) Data Exceeded Expectations, Expect Shares to Fly - Cantor Fitzgerald
Nov 25, 2019 06:41AM Apellis Pharmaceuticals (APLS) PT Raised to $54 at Cantor Fitzgerald Ahead of PEGASUS Near-Term Data
Mar 11, 2019 04:01PM Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Mar 11, 2019 12:01PM Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Mar 7, 2019 09:26AM Pre-Open Stock Movers 03/07: (ARQL) (ALSK) (GWRE) Higher; (APVO) (BPI) (KR) Lower (more...)
Mar 7, 2019 07:01AM Apellis Pharmaceuticals (APLS) Prices 6M Share Common Offering at $17/Sh
Mar 7, 2019 07:00AM Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Mar 7, 2019 07:00AM Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Mar 6, 2019 04:00PM Apellis Pharmaceuticals (APLS) to Offer $75M in Common Stock
Mar 6, 2019 04:00PM Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Mar 6, 2019 04:00PM Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Feb 28, 2019 11:45AM Apellis Pharmaceuticals (APLS) PT Raised to $57 at Cantor Fitzgerald on SFJ Pharmaceuticals Support
Sep 28, 2018 09:00AM Apellis Pharmaceuticals to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
Sep 28, 2018 09:00AM Apellis Pharmaceuticals to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
Jun 27, 2018 07:32AM Cantor Fitzgerald Reiterates Overweight on Apellis Pharmaceuticals (APLS) Following R&D Day
May 23, 2018 04:06PM UPDATE: Cantor Fitzgerald Starts Apellis Pharmaceuticals (APLS) at Overweight